HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

BIBF 1120

an antiangiogenic agent
Also Known As:
BIBF-1120; BIBF1120; intedanib
Networked: 45 relevant articles (4 outcomes, 18 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hilberg, Frank: 4 articles (12/2015 - 06/2008)
2. Kaiser, Rolf: 4 articles (02/2015 - 01/2010)
3. Stopfer, Peter: 4 articles (06/2011 - 10/2009)
4. Kaneda, Hiroyasu: 3 articles (02/2015 - 10/2010)
5. Temple, Graham: 3 articles (02/2014 - 10/2011)
6. Stopfer, P: 3 articles (08/2012 - 02/2010)
7. Kaiser, R: 3 articles (08/2012 - 06/2011)
8. Terashima, Masaaki: 2 articles (02/2015 - 10/2010)
9. Nakagawa, Kazuhiko: 2 articles (02/2015 - 10/2010)
10. Sarashina, Akiko: 2 articles (02/2015 - 10/2010)

Related Diseases

1. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
2. Neoplasms (Cancer)
3. Ovarian Neoplasms (Ovarian Cancer)
4. Idiopathic Pulmonary Fibrosis
5. Colorectal Neoplasms (Colorectal Cancer)

Related Drugs and Biologics

1. Paclitaxel (Taxol)
2. Carboplatin (JM8)
3. Cytotoxins
4. Protein-Tyrosine Kinases (Tyrosine Kinase)
5. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
6. docetaxel (Taxotere)
7. Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
8. sorafenib (BAY 43-9006)
9. pazopanib
10. 4- ((4- Fluoro- 2- methyl- 1H- indol- 5- yl)oxy)- 6- methoxy- 7- (3- (pyrrolidin- 1- yl)propoxy)quinazoline (AZD2171)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Heterologous Transplantation (Xenotransplantation)
3. Stents
4. Castration
5. Aftercare (After-Treatment)